Literature DB >> 3288696

Role of granulocyte/macrophage colony-stimulating factor in the regulation of murine alveolar macrophage proliferation and differentiation.

B D Chen1, M Mueller, T H Chou.   

Abstract

Granulocyte/macrophage (GM)-CSF is one of the hemopoietic growth factors that stimulates neutrophilic granulocyte and macrophage production by bone marrow progenitor cells. In this study, the effect of GM-CSF on the growth and differentiation of murine pulmonary alveolar macrophages (PAM) was investigated. In the presence of GM-CSF, normal murine PAM were induced to proliferate and develop into macrophage colonies with a dose-response curve similar to that of bone marrow GM colony-forming cells. PAM also responded to CSF-1, a lineage-restricted growth factor, but required much higher doses of CSF-1 and a longer incubation time for optimal colony formation. The proliferative response of PAM to CSF-1, however, was greatly enhanced by the concurrent addition of low doses of GM-CSF. In contrast, low doses of CSF-1 failed to potentiate the proliferative response of PAM to GM-CSF. Macrophages derived from GM-CSF cultures were rounder and less stretched and possessed less FcR-mediated phagocytic activity than cells produced in CSF-1 cultures. A study with hydrocortisone-induced monocytopenia showed that nearly one half of lung macrophages may be sustained by local proliferation of PAM without the continuous migration of blood monocytes. This study suggests that GM-CSF may play a major role in the production of PAM by two modes of action, 1) direct stimulation of cell proliferation and 2) enhancement of their responsiveness to CSF-1, thereby producing more mature and functionally competent macrophages.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3288696

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

Review 1.  Immunosenescence in monocytes, macrophages, and dendritic cells: lessons learned from the lung and heart.

Authors:  Phyllis-Jean Linton; Marilyn L Thoman
Journal:  Immunol Lett       Date:  2014-09-22       Impact factor: 3.685

2.  Essential Role of mTORC1 in Self-Renewal of Murine Alveolar Macrophages.

Authors:  Wenhai Deng; Jialong Yang; Xingguang Lin; Jinwook Shin; Jimin Gao; Xiao-Ping Zhong
Journal:  J Immunol       Date:  2016-11-23       Impact factor: 5.422

3.  Effect of hematopoietic growth factors on human blood monocytes/macrophages in in vitro culture.

Authors:  N F Hassan; J Chehimi; W Z Ho; D E Campbell; S D Douglas
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

Review 4.  The development and maintenance of resident macrophages.

Authors:  Elisa Gomez Perdiguero; Frederic Geissmann
Journal:  Nat Immunol       Date:  2016-01       Impact factor: 25.606

Review 5.  Immunodeficiency secondary to anticytokine autoantibodies.

Authors:  Sarah K Browne; Steven M Holland
Journal:  Curr Opin Allergy Clin Immunol       Date:  2010-12

6.  The lung is protected from spontaneous inflammation by autophagy in myeloid cells.

Authors:  Masashi Kanayama; You-Wen He; Mari L Shinohara
Journal:  J Immunol       Date:  2015-04-24       Impact factor: 5.422

Review 7.  Cells and molecules involved in the development of sarcoid granuloma.

Authors:  C Agostini; U Basso; G Semenzato
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.317

8.  Production of granulocyte-macrophage colony-stimulating factor by cultured human tracheal epithelial cells.

Authors:  L Churchill; B Friedman; R P Schleimer; D Proud
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

9.  Fatal hematophagic histiocytosis after granulocyte-macrophage colony-stimulating factor and chemotherapy for high-grade malignant lymphoma.

Authors:  B Risti; R F Flury; A Schaffner
Journal:  Clin Investig       Date:  1994-06

10.  Androgen and Androgen Receptor as Enhancers of M2 Macrophage Polarization in Allergic Lung Inflammation.

Authors:  Mireya Becerra-Díaz; Ashley B Strickland; Aleksander Keselman; Nicola M Heller
Journal:  J Immunol       Date:  2018-10-10       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.